Big Med-Tech Firms Train Device Regulators In Emerging Markets
This article was originally published in The Gray Sheet
Executive Summary
The largest multinational medical device companies are making an effort not only to lobby governments in emerging foreign markets to influence regulations, but to actually train the regulators on what industry sees as best practices